Key result
Direct epicardial assistance using a circumferential artificial rubber muscle device significantly improved cardiac output from 1.39 to 1.96 L/min (p=0.02) in a swine model of dilated cardiomyopathy.
Why the study?
Does a direct epicardial assist device using artificial rubber muscle improve hemodynamics in a swine model of pediatric dilated cardiomyopathy?
Does a direct epicardial assist device using artificial rubber muscle improve hemodynamics in a swine model of pediatric dilated cardiomyopathy?
Absolute Event Rate: 1.96% vs 1.39%
p-value: p=0.02
A direct epicardial assist device using artificial rubber muscles significantly improved cardiac output, stroke volume, and ejection fraction in a swine model of pediatric dilated cardiomyopathy.
Warrants no clinical adoption; hypothesis-generating for epicardial rubber muscle devices in dilated cardiomyopathy.
PURPOSE: Ventricular assist devices are a potent alternative or bridge therapy to heart transplants for dilated cardiomyopathy patients. However, ventricular assist devices have problems related to biocompatibility, hemocompatibility, and thromboembolic events, especially in younger patients. The present study examined the hemodynamic effects of a direct cardiac compression device using circumferential artificial rubber muscles in a young swine model of dilated cardiomyopathy. METHODS: Dilated cardiomyopathy was established in 6 pigs (6-8 weeks of rapid right ventricular pacing; average weight, 22.6 ± 2.1 kg). The device was designed using pneumatic rubber muscles (Fluidic Muscle, Festo). Hemodynamic parameters were monitored under baseline conditions, after the assistance, and after inducing ventricular fibrillation. Hemodynamic data were acquired using a PiCCO, multilumened thermodilution catheter in the pulmonary artery, left ventricular pressure monitoring, and epicardial echocardiography. RESULTS: Direct epicardial assistance resulted in a significant improvement in hemodynamic data. Cardiac output improved from 1.39 ± 0.24 L/min to 1.96 ± 0.46 (p = 0.02). Stroke volume (14.5 ± 3.2 mL versus 20.1 ± 4.3 ml, p<0.01) and ejection fraction (25.2 ± 3.6% versus 47.7 ± 7.8%, p<0.01) also improved after assistance. After inducing ventricular fibrillation, cardiac output was maintained at 1.33 ± 0.28 L/min. CONCLUSIONS: Use of a circumferential direct epicardial assistant device resulted in improvement in hemodynamic data in a dilated cardiomyopathy model. Although there is still a need for improvements in device components, the direct cardiac assist device may be a good alternative to recent heart failure device therapies.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2015) studied Dilated cardiomyopathy (n=6). Direct epicardial assist device using artificial rubber muscle vs. Baseline conditions was evaluated on Cardiac output (L/min) (p=0.02). Direct epicardial assistance using a circumferential artificial rubber muscle device significantly improved cardiac output from 1.39 to 1.96 L/min (p=0.02) in a swine model of dilated cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: